Product Information
PAROXETINE HCL 30 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0954 per EA under NDC 16714018301. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Jul 25, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714018301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA078406FDA Approved
7/25/2007
TE Code
AB
On Market Since
7/25/2007
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 30 MG TABLET has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0954 per EA |
|---|---|
| All-time high | $0.1374 (Aug 10, 2022) |
| All-time low | $0.0735 (Nov 20, 2024) |
| 52-week high | $0.1007 |
| 52-week low | $0.0940 |
| Median price | $0.0991 |
| Average price | $0.1050 |
| Largest weekly change | +27.2% (Nov 22, 2023) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Paroxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 30 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0954 per EA (NDC 16714018301), effective Sep 30, 2026.
How has the price of PAROXETINE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 30 MG TABLET has declined 25.5%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 30 MG TABLET?
Since Jul 13, 2022, the NADAC for PAROXETINE HCL 30 MG TABLET has ranged from a low of $0.0735 (Nov 20, 2024) to a high of $0.1374 (Aug 10, 2022), with a median of $0.0991 per EA.
Are there cheaper alternatives to PAROXETINE HCL 30 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PAROXETINE HCL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE HCL 30 MG TABLET?
PAROXETINE HCL 30 MG TABLET (NDC 16714018301) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.